Ahuwalia Contracts (India) (532811) Q4 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 25/26 earnings summary
4 Jun, 2026Executive summary
FY 2026 turnover was INR 4,565.20 crore (₹45,652 Mn), up 11.38% year-over-year; PAT was INR 264.32 crore (₹2,643 Mn), up 31.17% year-over-year.
Q4 FY 2026 turnover was INR 1,322.30 crore (₹13,223 Mn), up 8.76% year-over-year; PAT was INR 80.14 crore (₹801 Mn), down 3.63% year-over-year.
Gross order book reached ₹296,757 Mn as of March 31, 2026, with unexecuted orders at ₹210,963 Mn, executable over 24–30 months.
Operations span 53+ ongoing projects across 16 Indian states and one overseas location.
Audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, were approved, with unmodified audit opinions.
Financial highlights
FY 2026 EPS was INR 39.46 (₹39.46), up from INR 30.08 (₹30.08) in FY 2025; EBITDA margin at 9.52% vs. 8.34% year-over-year.
PAT margin for FY 2026 was 5.70% vs. 4.85% in FY 2025; Q4 FY 2026 PAT margin was 6.7%.
Net worth surpassed INR 2,000 crore (₹20,600 Mn) as of March 31, 2026.
Mobilization advance: INR 802 crore; retention: INR 450 crore; unbilled revenue: INR 638 crore.
Net cash position: INR 817 crore; margin money: INR 200 crore; cash and cash equivalents at year-end: ₹30,800.98 lakhs (standalone).
Outlook and guidance
FY 2027 revenue growth guidance is 15%-20%, with order inflow target of INR 8,000 crore (including L1 projects).
Double-digit EBITDA margin expected in FY 2027, supported by escalation clauses in 89% of order book.
H2 FY 2027 expected to be significantly stronger than H1 due to labor and election-related disruptions in H1.
CapEx for FY 2027 projected at INR 300 crore; depreciation to rise proportionally.
The Board is monitoring regulatory changes, including new labor codes, and pursuing amalgamation with five wholly owned subsidiaries.
Latest events from Ahuwalia Contracts (India)
- Q3 and nine-month FY26 delivered strong growth and margins, with a major subsidiary merger approved.532811
Q3 25/2613 Apr 2026 - FY25 revenue and order book grew, net profit declined, and a 30% dividend was recommended.532811
Q4 24/2520 Dec 2025 - Q2 FY25 revenue and profit rose, margins pressured, order book strong, clean audit review.532811
Q2 24/2519 Dec 2025 - Q1 FY26 delivered strong growth, higher margins, and a record order book, supporting future gains.532811
Q1 25/2619 Dec 2025 - Q3 FY25 turnover and PAT declined, but a strong order book supports double-digit margin outlook.532811
Q3 24/2519 Dec 2025 - Strong Q2 growth, record margins, and robust order book support a positive outlook.532811
Q2 25/2619 Dec 2025 - Q1 FY25 revenue up 20% YoY, margins down, but strong order book and positive outlook.532811
Q1 24/2519 Dec 2025